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ABSTRACT
Background Bronchiectasis is a chronic respiratory condition 
that impacts significantly on individuals and healthcare 
services. Self- management is recommended in clinical 
guidelines for bronchiectasis as an intervention to enable 
patients to manage their condition, yet there is little evidence 
to support it.
Methods Three face to face focus groups (17 adults with 
bronchiectasis) were conducted at three National Health 
Service (NHS) sites in North West England. Additionally, semi- 
structured telephone interviews were undertaken with 11 
healthcare professionals (HCPs), including doctors, nurses and 
physiotherapists. Thematic analysis identified common themes 
and occurrences verified by independent audit.
Findings Four common overarching themes were identified: 
the meaning of self- management; benefits; barriers and 
influencers to self- management; subthemes varied. Both 
groups recognised component interventions. Patients 
highlighted that self- management enabled them to learn 
what works and moderate behaviour. Aspects of delivery and 
structure were important to HCPs but a ‘make do’ culture 
was evident. Benefits for both groups included empowering 
patients. Common barriers for patients were time, mood and 
lack of access to support which could mitigate engagement 
with self- management. HCPs identified barriers including 
patient characteristics and lack of resources. Influencers for 
patients were peer, carer and psychosocial support, for HCPs 
influencers were individual patient attributes, including ability 
and motivation, and HCP characteristics such as knowledge 
and understanding about bronchiectasis.
Summary This is the first study to explore patients’ and 
HCPs’ views of self- management for bronchiectasis. The need 
for an individual, flexible and responsive self- management 
programme specific to bronchiectasis was evident. Personal 
characteristics of patients and HCPs could affect the 
uptake and engagement with self- management and HCPs 
knowledge of the disease is a recognised precursor to effective 
self- management. The study identified key aspects for 
consideration during development, delivery and sustainability 
of self- management programmes and findings suggest that 
patients’ psychosocial and socioeconomic circumstances may 
affect adoption and activation of self- management behaviours.
BACKGROUND
Bronchiectasis is a long- term respiratory 
condition with a significant impact on quality 
of life, morbidity, mortality and use of health-
care resources.1–3 The disease manifests as 
chronic airway inflammation, impaired muco-
ciliary clearance and structural lung damage 
leading to recurrent infections, persistent 
cough, sputum production and exacerba-
tions. Diagnosis is often clinically defined and 
confirmed by high- resolution CT (HRCT).4
The prevalence of bronchiectasis appears to 
be increasing, though true prevalence may be 
influenced by other factors such as improved 
diagnosis using HRCT and inaccurate diag-
nosis due to comorbidities.5–9
The aim of therapeutic management is to 
break the recurrent cycle of inflammation 
and infection, to preserve lung function, 
reduce exacerbations and complications, 
and improve health- related quality- of- life.10 11 
Antibiotics are the frontline therapy for bron-
chiectasis and most international guidelines 
also recommend airway clearance tech-
niques (ACT) and pulmonary rehabilitation 
(PR).1 10–12
Key messages
What is the key question?
 ► What are the views, preferences and experiences 
of patients and healthcare professionals (HCPs) re-
garding self- management for bronchiectasis?
What is the bottom line?
 ► An individualised, flexible and responsive self- 
management programme is needed for patients with 
bronchiectasis, provided by HCPs knowledgeable 
about the disease and management.
Why read on?
 ► This qualitative study has revealed key consider-
ations that will inform development and delivery of 
future self- management programmes for patients 
with bronchiectasis. Future research is needed 
to explore further the influence of psychosocial 
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Self- management has been defined as actions taken by 
individuals and others to mitigate the effects of a long- 
term condition and maintain a good quality- of- life.13 
Self- management strategies have improved quality- of- life 
and reduced service burden in other chronic respiratory 
conditions such as chronic obstructive pulmonary disease 
(COPD) and asthma,14 15 with potential to achieve similar 
benefits in bronchiectasis. Adherence to prescribed treat-
ment may be poor16 and it is therefore vital that patients 
are supported to manage their condition more effectively.
International guidelines for bronchiectasis include 
recommendations for self- directed activities such as exer-
cise and ACT,1 10–12 but the majority do not specifically 
refer to self- management or patient education. However, 
the most recent British Thoracic Society guidelines 
explicitly recommend that ‘people with bronchiectasis 
have an individualised written self- management plan’ as 
the first element of a five- step plan.10
A Cochrane systematic review of self- management 
interventions found insufficient evidence to assess the 
benefits for patients with bronchiectasis17 and added to 
the call for research to define and develop these inter-
ventions.9 10 18 The aim of this study was to explore views 
of self- management with key stakeholders to inform the 




This was an inductive exploratory qualitative study 
including patient focus groups and one to one interviews 
with HCPs. These complementary approaches reinforced 
validity through methodological and participant triangu-
lation. Triangulation refers to comparison and meshing 
of different data to enhance credibility and add depth to 
findings.19
Patient and public involvement
A project steering group was convened and consulted 
on key project decisions, this included members of the 
multidisciplinary team with an interest in bronchiec-
tasis and three patient representatives of different ages, 
employment status and levels of morbidity. These patient 
representatives guided and commented on study mate-
rials and the interview schedules.
Participant recruitment
Patients and HCPs were recruited on a voluntary basis by 
three independent institutional gatekeepers (clinicians) 
based in three National Health Service (NHS Trusts in 
the North West of England. Inclusion criteria for patients 
were: >18 years; diagnosis of bronchiectasis confirmed 
by HRCT; English speaking. Patients were excluded if: 
they had a diagnosis of bronchiectasis secondary to cystic 
fibrosis; or had an acute exacerbation at the point of 
recruitment. Inclusion criteria for HCPs were: >18 and 
involved in the care of patients with a diagnosis of bron-
chiectasis. All participants were provided with an informa-
tion sheet explaining the study and given an opportunity 
to ask questions prior to and after providing informed 
consent.
Data collection
Interview and focus group schedules were developed 
based on factors related to self- management harvested 
from previous systematic reviews,17 20 and published 
guidelines,10 11 including a search of grey literature. This 
was supported by a call through professional organi-
sations for relevant local policies. The draft interview 
schedules were discussed and finalised with the project 
steering group which included PPI.
Three focus groups were conducted with adult patients 
by two researchers (DL, AT) from May to October 2019. 
Semi- structured telephone interviews with HCPs caring 
for adult bronchiectasis patients were conducted by AT 
between February and April 2019. All data were digitally 
recorded and transcribed verbatim (AT).
Data analysis
We used a thematic approach to data analysis21; this 
requires the researcher to familiarise themselves with 
the data in order that common themes, occurrences and 
outliers are identified to provide some level of under-
standing, explanation and interpretation. While the 
findings may not be generalisable it may be possible to 
draw tentative conclusions that may be applicable to a 
wider population. A number of procedures were adopted 
to safeguard and maintain authenticity and credibility, 
these included independent audit by a second member 
of the research team and the use of verbatim quotes. 
Individual interviews were primarily analysed by CK and 
focus groups by DL.
FINDINGS
A total of 17 participants took part in three focus groups. 
Eleven HCP interviews were conducted at three different 
NHS sites in the North West of England. All focus groups 
lasted for between 60 and 90 min and interviews lasted 
30 min on average. Sociodemographic details of patients 
were recorded to enable transcripts to be analysed 
in context (table 1). The demographic data of HCPs 
(table 2) were recorded to establish clinical experience 
of individuals and context of their clinical practice as 
related to self- management of patients with bronchiec-
tasis.
For patients and HCPs we identified four common over-
arching themes: the meaning of self- management; benefits; 
barriers and influencers to self- management and subthemes 
that differed between the two groups (table 3). The 
themes are discussed later supported by verbatim quotes: 
patients and HCPs are identified with a number, for 
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example, P7, followed by the line number in the tran-
script, for example, HCP4:46.
Meaning of self-management: patients
Patients and HCPs discussed their definition and inter-
pretation of self- management. For patients, this theme 
comprised identification of components of self- management, 
learning what works and moderating behaviour. Components 
included chest clearance and breathing control, medica-
tion and rescue packs, education (of self and carers), diet 
and exercise. Learning what works for them was deemed 
important, giving a sense of autonomy and control:
‘… you can reduce it [medication] and you’re okay’ 
… So, I’ve reduced it … it’s a good side to control, 
to be able to do it yourself, but you have to be very 
careful, don’t just stop it. (P3:507)
Making autonomous decisions under the direction of 
a clinician was recognised as a significant part of self- 
management and patients were aware of the impor-
tance of compliance and moderating behaviour. This was 
discussed openly:
If you’re not prepared to do exercises and do 
everything you’re supposed to, like take your 
medicine, then it’s not going to work. (P15:32)
Patients overall felt positive about self- management, 
some related it to specific models of delivery, for instance 
PR, but most recognised it as a way of enabling them to 
control their condition.
Meaning of self-management: HCPs
HCPs similarly offered insight regarding components of 
interventions that included patient education sessions 
(disease and course of disease, smoking cessation, diet, 
influenza vaccinations, avoiding infection, travel, etc), 
information for patients regarding who and when to 
contact for advice, chest clearance exercises and devices, 
coping strategies, and benefits of general exercise. Recog-
nising signs of infection early was stressed, with prompt 
action and follow- up recommended.
Table 1 Participant characteristics of focus groups
Gender Male (n=5), female (n=12)
Age (years) Mean (72.94), median (71), range 
(62–88)
Employment status Retired (n=16), self- employed (n=1)
Area Rural (n=5), urban (=12)
Comorbidities Multiple (n=7; range 2–7), one (n=8), 
none (n=2)
Marital status Married (n=10), single/living alone 
(n=7)




clinical role Specialist area of practice






in an average 
month





HCP2 Physiotherapist 24 years Medicine and respiratory care Secondary care 13
HCP3 Physiotherapist 12 years Respiratory/self- management Primary care—
community
10–20
HCP4 GP 18 months Chronic respiratory diseases Primary care 30
HCP5 Physiotherapist 17 years Respiratory Primary care 10
HCP6 Respiratory medical 
consultant
6 years Cystic fibrosis and 
bronchiectasis
Secondary care 60
HCP7 Respiratory nurse 13 years Respiratory Integrated care 50
HCP8 Respiratory nurse 6 years Respiratory Primary care 10
HCP9 Respiratory nurse 7 years COPD and bronchiectasis Primary and 
secondary care
10–20
HCP10 Respiratory registrar 2 years Occupational respiratory 
disease
Secondary care 8–10
HCP11 Physiotherapist 29 years Respiratory Primary and 
secondary care
6–10
COPD, chronic obstructive pulmonary disease; HCP, healthcare professional.
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Discussion of delivery and structure in relation to inter-
ventions was prominent in all HCPs’ responses with 
many advocating PR as a format for introducing self- 
management. Integration as part of the clinical pathway 
was also recognised, with emphasis, but not consensus, 
regarding optimal delivery of education sessions:
One to one because I think some of the quieter 
patients who have less understanding will feel more 
confident to ask questions, but in a group I think 
people will also hear the way someone else might 
manage their condition or might recommend 
something they have not thought of. (HCP7:169)
Others spoke of whether an education session should 
be for individuals with single disease or whether mixed 
disease cohorts were feasible, again no consensus was 
apparent, but availability of resources governed this to 
some extent.
All participants were asked about their thoughts on 
technology for guiding self- management; responses 
varied with some HCPS favouring digital technologies 
while the benefits were unclear to others:
The number of apps in asthma have shown never 
to work, so … why would it work in bronchiectasis? 
(HCP6:110)
Patients’ motivation, employment status, age and 
whether ‘technology savvy’ (HCP3:158) were factors 
cited for engagement with technology. Overall, there 
was no consensus regarding benefits of technologies to 
support self- management interventions.
Benefits of self-management: patients
Exacerbations were considered important to patients 
because of the impact on lifestyles and coping 
mechanisms. The self- management plan was referred to 
as a way of enabling patients to manage and prevent exac-
erbations. This enabled one individual to avoid taking 
antibiotics that were associated with uncomfortable side 
effects:
… I couldn’t get rid of the infection. So, they kept 
giving me antibiotics, which were making me not well 
and making my skin all blotchy and whatever. And I 
see [doctor’s name] … he gave me a self- management 
plan and that was in March and I’ve done it ever since 
… And I haven’t had any antibiotics at all. (P14:11)
Some described benefits of self- management as a proxy 
for HCPs when there was no access. Patients also used 
self- management techniques to control anxiety about their 
condition.
Benefits of self-management: HCPs
HCPs regarded self- management as a method of empow-
ering patients, enhancing their self- care abilities:
I think it puts the patient right at the centre of care. 
(HCP3:115)
HCPs considered self- management as conferring 
control and ownership for patients, reinforcing self- 
confidence. Clinical outcomes were directly related to self- 
management with earlier identification and intervention 
resulting in fewer exacerbations with quality- of- life bene-
fits for patients. Psychosocial benefits were also recognised, 
particularly increased confidence and independence:
At the end (of the exercise programme), they’ll be 
better, and it makes a difference to their everyday 
life. (HCP1:83)
Table 3 Overarching themes and subthemes
Meaning of self- management
Patients HCPs




Components Delivery and structure
Benefits of self- management
Patients HCPs
Manage and prevent 
exacerbations




Barriers to self- management
Patients HCPs
Time- consuming Lack of access to 
HCPs
Mood Characteristics of the 
patient
Lack of tools/resources resentment
Influencers on self- management
Patients HCPs
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HCP’s also noted the benefits of peer support for 
increasing self- confidence, sometimes through attending 
PR or group education sessions.
Barriers to self-management: patients
Patients discussed the challenges of balancing time- 
consuming treatment against personal commitments, 
such as caring responsibilities that may lead to negative 
impacts on self- management:
I sometimes have to shorten one of my inhaling 
things because I haven’t got the time. (P15:121–122)
Lack of access to HCPs with appropriate specialist training 
and access to reliable information on bronchiectasis also 
featured in discussions:
I went to my GP and tried to speak to a physio and 
a respiratory nurse. They both said, I don’t know 
anything about it [bronchiectasis] and that I’ll 
have to speak to my specialist. Actually, trying to get 
information to how to manage it was really, really 
difficult. (P17:238–241)
Long waiting lists, lack of continuity and consistency of 
care were also seen as barriers:
… it’s just amazing, you never see the same person 
twice. (P13:214)
Patients talked about their mood as influencing their 
ability to engage in self- management featuring lethargy, 
fatigue and depression:
It’s the pure tiredness. You’re really exhausted, and 
you think, ‘I’ve got to set the machine up and I can’t 
be bothered’.’ (P6:A607)
Feeling down when quality- of- life is perceived to 
be poor was also linked to a lack of motivation for 
self- management:
I think when you’ve had infection, after infection, 
after infection you just go so low … you know, why 
me, what have I done to deserve this and all that type 
of stuff. I start to feel very sorry for myself. (P10:301)
Barriers to self-management: HCPs
HCPs also felt that characteristics of patients, for instance 
low levels of resilience, impacted on patients’ motivation 
and ability to self- manage:
Sometimes patients just don’t have the same coping 
strategies to deal with tasks that they need to do for 
self- management. (HCP11:136)
Physical symptoms were also deemed to impact; cough 
was a significant issue that affected patients’ abilities 
to attend group gatherings and therefore engage in 
self- management:
A lot of people don’t like coughing … You have 
to expect people to expectorate and certainly for 
women there’s a social stigma towards coughing 
sputum. (HCP9:124)
Coughing was linked to fatigue and social isolation 
which was felt to impact further on patients’ motivation 
and abilities: a combination of barriers preventing effec-
tive engagement in self- care: ‘It’s hard work for them’ 
(HCP2: 66).
… if somebody is socially isolated, hasn’t gone out, 
fatigued, struggling with symptom burden, their 
mood’s low, their self- worth comes down, they 
think of themselves as disgusting and somebody 
who nobody wants to be around. It all just has this 
negative spiralling effect. (HCP3: 272)
Finally, lack of tools and/or resources was regarded as a 
significant barrier to HCPs promoting and supporting 
self- management. Some admitted that as services were 
‘geared towards COPD’ they often had to make do with 
available resources:
We’ll give them [patients with bronchiectasis] the 
same leaflets, but we just explain to them that you 
haven’t got COPD you’ve got bronchiectasis, but it’s 
similar signs and symptoms of a chest infection and 
what to do next. (HCP8:205)
In relation to efficient delivery of self- management 
interventions, participants voiced frustration with 
clinic waiting lists, understaffing, and lack of patient 
information.
Influencers on self-management: patients
Relatedly to HCPs highlighting the benefits of peer 
support, patients also valued peer, carer and social support 
and format of groups (citing the focus group in this 
extract) was deemed to be helpful:
… I think focus groups like this enables people with 
the same problems get together and bouncing off 
each other. (P12:106
In some cases, family members themselves delivered 
interventions such as chest physiotherapy. In this context 
participants acknowledged the need to educate the 
family and carers in addition to themselves. For those 
who lived alone, reliance on friends and neighbours was 
important, sometimes just needing somebody to ‘bounce 
off’ (P7:319).
Knowledge of HCPs was viewed as fundamental to 
patients’ engagement with self- management. Physiother-
apists were recognised as central to care and patients 
were aware of the significance of specialist clinicians in 
contrast to generalists:
They have asthma nurses in GP surgeries. But when 
it comes to bronchiectasis … I don’t think people are 
educated at all. (P6:363–364)
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Overall, accessibility of help and support and respon-
siveness of HCPs enabled patients to feel confident with 
their regimes.
In addition to a need for symptom support, patients 
recognised the need for psychological support, citing 
engagement in activities such as mindfulness, meditation 
and yoga. Patients were aware of and discussed occur-
rence and repercussions of anxiety.
Influencers on self-management: HCPs
In addition to being a barrier to self- management, charac-
teristics of patients were also seen as an influencer if strate-
gies could be tailored to individual needs:
Everyone is different. Everyone’s symptoms are 
different. Everyone experiences a condition in a 
different way. (HCP9:167)
It’s not one size fits all (HCP2:106)
Patients’ motivation was discussed in terms of priorities 
and passivity. Participants referred to patients’ desire for 
information and a willingness to learn, attributes driven 
by personal priorities:
If it doesn’t feel important, then they can’t find their 
own reason to do it, then they probably don’t do it. 
(HCP3:104)
Ability to self- manage was perceived by HCPs to be 
central to engagement with and optimisation of interven-
tions. This subtheme comprised several aspects including 
patients’ literacy and comprehension skills, presence 
of comorbidities, their ability and willingness to accept 
responsibility, and resilience. Regarding autonomy, HCPs 
related this to levels of confidence and their level of acti-
vation, sometimes measured using Patient Activation 
Measures:
… tells us how engaged and activated and 
knowledgeable for someone to manage their 
condition … (HCP5:81)
The relevance of demographics to self- management 
was at times contradictory:
So younger people are more engaged with self- 
management (HCP10:32)
I don’t think age comes into it. We’ve got fantastic 
patients who are in their 80s and 90s; they’re very 
sharp, they know their condition, they’re more than 
capable to self- manage. (HCP8:230)
Although patient characteristics featured in HCPs 
responses, it was also evident that HCPs influence patients’ 
engagement with self- management. Like patients, the 
importance of knowledge, skills and education were 
highlighted, particularly in relation to a lack of awareness 
regarding the disease and management:
… among healthcare professionals, bronchiectasis 
isn’t well recognised or understood. It’s often 
managed like another lung disease or a serious chest 
infection. (HCP3:203)
A few HCPs attributed improvements in care to key 
individuals in the multiprofessional team who champion 
bronchiectasis, in contrast lack of generalists’ knowledge 
of the condition was highlighted as a potential issue:
How knowledgeable is their GP or nurse on 
bronchiectasis to be able to explain it to them? 
(HCP10:229)
Importance of guidelines was recognised as a key driver 
for the use of action plans. Coworking and partnership 
were recognised as important for a few, acknowledging 
the relevance of patients' and HCPs' shared responsibility 
in the processes of self- management.
DISCUSSION
We explored patients’ and clinicians’ views of the self- 
management of bronchiectasis. Our findings highlighted 
components of self- management programmes and 
aspects of delivery considered to be important. Moreover, 
potential barriers to effective implementation were iden-
tified.
Structure, delivery and resources
We did not identify formal, structured self- management 
programmes, but we did find that current guideline 
recommended evidence- based single interventions, such 
as exercise and ACT, are often incorporated into daily 
patient routines. Regular exercise as part of formal PR 
programmes is recommended for patients with bron-
chiectasis,10 11 and has been shown to improve health 
outcomes22 23; endorsed further by association between 
sedentary behaviour and increased risk of hospitalisa-
tion.24 ACT was also promoted as an intervention but 
was recognised as time consuming for patients. ACT is 
often underused and associated with poor compliance, 
with the biggest take- up by those with the most severe 
disease.25 It remains unclear whether a more structured 
approach to self- management would benefit adherence 
to such interventions, but motivation of the patient to 
engage with treatment regimens is clearly important.
Action or self- management plans were used by patients 
and HCPs to guide management of symptoms, interven-
tions and exacerbations. Self- management interventions 
that include an action plan have been found to improve 
quality- of- life and reduce hospital admissions in COPD,14 
although evidence of efficacy in asthma is lacking.26 
In bronchiectasis research is scarce; a randomised 
control trial evaluating a Bronchiectasis Empowerment 
Tool containing an action plan reported no positive 
outcomes.27 However, the intervention was burdensome 
(48 pages long) leading to 50% loss of participants who 
were reluctant to engage either because it was arduous, 
or they had developed their own self- management tech-
niques.27 There is clearly a need for self- management 
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tools that are acceptable to patients and do not add to 
disease burden; timing of the introduction to the inter-
vention in relation to the point of diagnosis may also be 
important.
No consensus, from either patients or HCPS, was 
found to support or refute the use of technology to facil-
itate self- management. Feasibility and high demand for 
online access to a web- based bronchiectasis informa-
tion resource has been demonstrated, but this is yet to 
be proven in a full clinical trial.28 The UK Government’s 
digital inclusion strategy identified key barriers including 
age and social deprivation, that should be considered in 
design of self- management programmes.29
Availability of resources was a key factor with a scarcity 
of high- quality information and evidence of a ‘make do’ 
culture. Lack of materials have been previously identi-
fied as an obstacle to effective self- management.30 Lack 
of availability of specific resources may be perpetuated 
by a lack of knowledge and understanding of bronchiec-
tasis among generalist HCPs, as highlighted in our study. 
Specialist education in respiratory care has been found to 
increase knowledge and impact positively on practice.31 32
Views regarding duration of programmes, review and 
follow- up varied. For some, contrast between a clin-
ical setting and the patient’s own home was considered 
important alongside the ability to design interventions to 
suit local needs.
Individual approach
One size does not fit all, and it was clear that a tailored, 
personalised approach to self- management was preferred 
by both groups. This notion aligns to the approach of 
treatable traits and precision medicine, which may provide 
better outcomes for patients with bronchiectasis through 
a more personalised and precise management plan.33 
Self- management needs to be tailored to individual 
patients and their condition, as recognised in the PRISMS 
taxonomy of activities supporting self- management in 
long- term conditions.34
Peer support was aligned to patients’ adherence, moti-
vation and general outlook, with advantages in terms 
of psychological well- being. The merits of peer support 
have been highlighted previously35 but not always prior-
itised by HCPs who often favour symptom management 
and clinical outcomes.36 Peer support has been found 
to sustain change in health behaviours37 and patients’ 
engagement with self- management.30 Consensus from 
our study demonstrates that patients benefit from 
peer support, but it is unclear whether one- to- one self- 
management programmes or a group format are most 
beneficial.
The ability and desire for patients to engage with self- 
management was a significant factor for HCPs and the use 
of tools to gauge patient activation was reported. Patient 
activation is described as knowledge, confidence and 
ability to self- manage chronic illness and can be assessed 
by using the Patient Activation Measure.38 It has been 
suggested that HCPs educated and trained in supporting 
behaviour change, as well as the specific condition, have 
more success with patient activation.39 This could be an 
important and useful consideration for future bronchiec-
tasis self- management intervention programmes.
Both groups recognised the impact of mood on 
engagement with self- management activity especially if 
depression was manifest. Self- management can motivate 
individuals and reduce anxiety by providing patients with 
a sense of control, a lack of which can impact negatively 
on a patient’s quality- of- life.2 This can influence moti-
vation and adherence and is likely intrinsically linked 
to availability of social support networks and mitigation 
of factors associated with poor adherence.16 40 A recent 
review has developed a programme theory postulating 
that increasing awareness of psychological and social 
factors may trigger short- term improvements in self- 
efficacy and quality- of- life in a well- informed population 
of bronchiectasis patients.20
Other sociodemographic factors, such as family support 
and finances, may also be relevant to a patient’s ability 
to engage with self- management. There is a recognised 
social gradient in the health and care of people with 
bronchiectasis showing that those from deprived commu-
nities have worse outcomes.8 41 It is not clear whether this 
is related to better access to healthcare or confounding 
factors such as smoking and higher incidence of comor-
bidity in deprived areas.8 More affluent groups may 
self- manage more effectively and have greater access 
to specialist services, which may impact on survival.42 
Influence of factors such as literacy, health beliefs and 
economic factors are less well understood and require 
further study.
Differences in perceptions from patient focus groups 
were noted and may be explained by demographics. For 
example, those living in rural areas appeared fitter and 
travelled further to participate in the study. The urban 
group however were less mobile, and a few were wheel-
chair users. Inclusion of patients from rural commu-
nities addresses one of the limitations in Lavery et al’s 
paper30 and our findings suggest that those living in rural 
communities may be more inclined to engage in exer-
cise and self- management activities, and generally have 
a more positive outlook on life. However, this could also 
be explained by people in rural areas needed to travel 
further to attend the focus groups and therefore had to 
be fitter to get there. This has implications regarding 
access to self- management and support groups in rural 
areas.
Strengths and limitations
A strength of our study was inclusion of HCPs’ perspec-
tives thus addressing a current gap in evidence. Involve-
ment of patient representatives on the project steering 
group provided insightful direction during the design 
and conduct of the study. Additionally, recruitment of 
patients across a range of urban and rural areas provided 
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some, although limited, insight into socioeconomic 
factors. Key limitations relate to the generalisability of 
our population, who were based in one English region 
and most patients were retired. Their views may not be 
representative of the wider bronchiectasis population.
SUMMARY
This is the first study to explore both patients’ and HCPs’ 
views of self- management for bronchiectasis, acknowl-
edging both advantages and barriers. Patients valued 
peer learning while HCPs acknowledged that ‘not one 
size fits all’. Patient motivation is clearly important and 
linked to acceptability of interventions. The need for 
an individual, flexible and responsive self- management 
intervention was evident and relevant professional knowl-
edge was essential for effective delivery. It is clear that 
patients’ psychosocial and socioeconomic circumstances 
may influence adoption of self- management interven-
tions and activation of self- management behaviours and 
that personal characteristics of patients and HCPs could 
affect uptake and engagement with interventions.
This study has identified key aspects for consider-
ation that will inform future development, delivery and 
sustainability of self- management programmes for adults 
with bronchiectasis. Although consensus on the design, 
structure and delivery of self- management programmes 
was not evident, other potentially facilitating aspects 
were apparent. These include the need to direct atten-
tion to an individual, tailored approach that reflects 
both local needs, including accessibility, and availability 
of resources. Acceptability to patients is important and 
any self- management intervention should not add to the 
disease burden, thus optimising motivation. Education of 
HCPs will be crucial to any self- management programmes 
and should include training for supporting behaviour 
change. Future research should aim to elicit additional 
information on the influence of psychosocial determi-
nants of patients’ engagement with self- management 
interventions including literacy, health beliefs, economic 
factors, and peer/social support.
Contributors CAK: conceived the idea, sourced funding, developed the protocol, 
sought ethical and other permissions, acted as principal and chief investigator 
and was accountable for all aspects of the work related to the accuracy/integrity 
of any part of the work, analysed the findings and developed the manuscript. 
AT: developed the protocol, assisted in day- to- day operational running of the 
study, recruited participants, gained signed informed consent, collected the data, 
sought ethical and other permissions, analysed the findings and contributed to 
the manuscript development. DL: developed the protocol, recruited participants, 
gained signed informed consent, collected the data, analysed the findings and 
contributed to the manuscript development. SS: conceived the idea, sourced 
funding, developed the protocol, provided professorial support and advice to the 
research team and contributed to the manuscript development with final approval 
of the version published.
Funding This work was supported by a grant from Edge Hill University Research 
Investment Fund (1KELLY16).
Competing interests None declared.
Patient and public involvement Patients and/or the public were involved in the 
design, or conduct, or reporting, or dissemination plans of this research. Refer to 
the Methods section for further details.
Patient consent for publication Not required.
Ethics approval This study was approved by NHS London Harrow Research Ethics 
Committee (ref 18/LO/1671).
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available upon reasonable request. Original 
data are available upon reasonable request from corresponding author:  kellyc@ 
edgehill. ac. uk.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non- commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the 
use is non- commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
ORCID iD
Carol Ann Kelly http:// orcid. org/ 0000- 0002- 9927- 1382
REFERENCES
 1 Chang AB, Bell SC, Torzillo PJ, et al. Chronic suppurative lung 
disease and bronchiectasis in children and adults in Australia 
and New Zealand thoracic Society of Australia and New Zealand 
guidelines. Med J Aust 2015;202:21–3.
 2 Dudgeon EK, Crichton M, Chalmers JD. "The missing ingredient": 
the patient perspective of health related quality of life in 
bronchiectasis: a qualitative study. BMC Pulm Med 2018;18:81.
 3 Goeminne PC, Hernandez F, Diel R, et al. The economic burden of 
bronchiectasis - known and unknown: a systematic review. BMC 
Pulm Med 2019;19:54.
 4 Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in 
adults. Eur Respir J 2015;45:1446–62.
 5 O'Brien C, Guest PJ, Hill SL, et al. Physiological and radiological 
characterisation of patients diagnosed with chronic obstructive 
pulmonary disease in primary care. Thorax 2000;55:635–42.
 6 Goeminne PC, De Soyza A. Bronchiectasis: how to be an orphan 
with many parents? Eur Respir J 2016;47:10–13.
 7 Quint JK, Millett ERC, Joshi M, et al. Changes in the incidence, 
prevalence and mortality of bronchiectasis in the UK from 
2004 to 2013: a population- based cohort study. Eur Respir J 
2016;47:186–93.
 8 Snell N, Gibson J, Jarrold I, et al. Epidemiology of bronchiectasis 
in the UK: Findings from the British lung foundation's 'Respiratory 
health of the nation' project. Respir Med 2019;158:21–3.
 9 Aliberti S, Sotgiu G, Lapi F, et al. Prevalence and incidence of 
bronchiectasis in Italy. BMC Pulm Med 2020;20:15.
 10 T Hill A, L Sullivan A, D Chalmers J, et al. British thoracic Society 
guideline for bronchiectasis in adults. Thorax 2019;74:1–69.
 11 Polverino E, Goeminne PC, McDonnell MJ, Pieter C, et al. European 
respiratory Society guidelines for the management of adult 
bronchiectasis. Eur Respir J 2017;50:1700629.
 12 McShane PJ, Naureckas ET, Tino G, et al. Non- Cystic fibrosis 
bronchiectasis. Am J Respir Crit Care Med 2013;188:647–56.
 13 Taylor SJC, Pinnock H. Supported self- management for respiratory 
conditions in primary care. Primary Care Respiratory 2017;4:11–15.
 14 Lenferink A, Brusse- Keizer M, van der Valk PD, et al. Self- 
Management interventions including action plans for exacerbations 
versus usual care in patients with chronic obstructive pulmonary 
disease. Cochrane Database Syst Rev 2017;8:CD011682.
 15 Peytremann- Bridevaux I, Arditi C, Gex G, et al. Chronic disease 
management programmes for adults with asthma. Cochrane 
Database Syst Rev 2015;5:CD007988.
 16 McCullough AR, Tunney MM, Elborn JS, et al. 'All illness is personal 
to that individual': a qualitative study of patients' perspectives 
on treatment adherence in bronchiectasis. Health Expect 
2015;18:2477–88.
 17 Kelly C, Grundy S, Lynes D, et al. Self- Management for 
bronchiectasis. Cochrane Database Syst Rev 2018;2:CD012528.
 18 Kelly CA, Kirkcaldy AJ, Pilkington M, et al. Research priorities 
for respiratory nursing: a UK- wide Delphi study. ERJ Open Res 
2018;4:00003-2018–2018.
 19 Seale C, Silverman D. Ensuring rigour in qualitative research. Eur J 
Public Health 1997;7:379–84.
 20 Tsang A, Lynes D, McKenzie H. P246 a systematic review of self- 
management support interventions for adult bronchiectasis patients: 
a realist synthesis. Thorax 2019;74:A223–4.
 21 Braun V, Clarke V. Using thematic analysis in psychology. Qual Res 
Psychol 2006;3:77–101.
 22 Annoni S, Bellofiore A, Repossini E, et al. Effectiveness of chest 
physiotherapy and pulmonary rehabilitation in patients with non- 
copyright.
 on M











es: first published as 10.1136/bm





Kelly CA, et al. BMJ Open Resp Res 2021;8:e000862. doi:10.1136/bmjresp-2020-000862 9
Open access
cystic fibrosis bronchiectasis: a narrative review. Monaldi Arch Chest 
Dis 2020;90. doi:10.4081/monaldi.2020.1107. [Epub ahead of print: 
12 Feb 2020].
 23 Patel S, Cole AD, Nolan CM, et al. Pulmonary rehabilitation 
in bronchiectasis: a propensity- matched study. Eur Respir J 
2019;53:1801264.
 24 Alcaraz- Serrano V, Gimeno- Santos E, Scioscia G, et al. 
Association between physical activity and risk of hospitalisation in 
bronchiectasis. Eur Respir J 2020;55:1902138.
 25 Basavaraj A, Choate R, Addrizzo- Harris D, et al. Airway clearance 
techniques in bronchiectasis: analysis from the United States 
bronchiectasis and non- TB mycobacteria research registry. Chest 
2020;158:1376–84.
 26 Gatheral TL, Rushton A, Evans DJ, et al. Personalised asthma 
action plans for adults with asthma. Cochrane Database Syst Rev 
2017;4:CD011859.
 27 Brockwell C, Stockl A, Clark A. Randomised controlled trial of the 
effect, cost and acceptability of a bronchiectasis self- management 
intervention. Chron Respir Dis 2020.
 28 Hester KLM, Ryan V, Newton J, et al. Bronchiectasis information and 
education: a randomised, controlled feasibility trial. Trials 2020;21:331.
 29 UK Government. Government digital inclusion strategy, 2014. 
Available: https://www. gov. uk/ government/ publications/ government- 
digital- inclusion- strategy/ government- digital- inclusion- strategy 
[Accessed 23 Nov 2020].
 30 Lavery K, O'Neill B, Elborn JS, et al. Self- Management 
in bronchiectasis: the patients' perspective. Eur Respir J 
2007;29:541–7.
 31 Kelly C. Does specialist respiratory education make a difference to 
practice? Nurse Educ Pract 2010;10:308–15.
 32 Guo S- E, Shen H- C, Okoli C, et al. Generalist versus specialist 
nurses' knowledge, attitudes, and behavioral intentions toward 
promoting pulmonary rehabilitation for patients with chronic 
obstructive pulmonary disease: a cross- sectional correlational study. 
Medicine 2018;97:e12975.
 33 Boaventura R, Sibila O, Agusti A, et al. Treatable traits in 
bronchiectasis. Eur Respir J 2018;52:1801269.
 34 Taylor SJC, Pinnock H, Epiphaniou E. A rapid synthesis of the 
evidence on interventions supporting self- management for people 
with long- term conditions: prisms – practical systematic review of 
self- management support for long- term conditions. NIHR Journals 
Library 2014.
 35 Hughes S, Lewis S, Willis K, et al. The experience of facilitators 
and participants of long term condition self- management group 
programmes: a qualitative synthesis. Patient Educ Couns 
2017;100:2244–54.
 36 Hughes S, Lewis S, Willis K, et al. Participants' experiences of 
and perceived value regarding different support types for long- 
term condition self- management programmes. Chronic Illn 
2019:174239531986943.
 37 Oates GR, Niranjan SJ, Ott C, et al. Adherence to pulmonary 
rehabilitation in COPD: a qualitative exploration of patient 
perspectives on barriers and facilitators. J Cardiopulm Rehabil Prev 
2019;39:344–9.
 38 Hibbard JH, Stockard J, Mahoney ER, et al. Development of 
the patient activation measure (PAM): conceptualizing and 
measuring activation in patients and consumers. Health Serv Res 
2004;39:1005–26.
 39 Greene J, Hibbard JH, Alvarez C, et al. Supporting patient behavior 
change: approaches used by primary care clinicians whose patients 
have an increase in activation levels. Ann Fam Med 2016;14:148–54.
 40 McCullough AR, Ryan C, O'Neill B, et al. Defining the content and 
delivery of an intervention to change adherence to treatment in 
BonchiEctasis (CAN- BE): a qualitative approach incorporating 
the theoretical domains framework, behavioural change 
techniques and stakeholder expert panels. BMC Health Serv Res 
2015;15:342.
 41 Roberts ME, Lowndes L, Milne DG, et al. Socioeconomic 
deprivation, readmissions, mortality and acute exacerbations of 
bronchiectasis. Intern Med J 2012;42:e129–36.
 42 British Lung Foundation (BLF). The battle for breath: the impact 
of lung disease in the UK, 2016. Available: https://www. blf. org. uk/ 
policy/ the- battle- for- breath- 2016 [Accessed 23 Nov 2020].
copyright.
 on M











es: first published as 10.1136/bm
jresp-2020-000862 on 4 M
arch 2021. D
ow
nloaded from
 
